Correlation Between Salesforce and Boundless Bio,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Boundless Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Boundless Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Boundless Bio, Common, you can compare the effects of market volatilities on Salesforce and Boundless Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Boundless Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Boundless Bio,.

Diversification Opportunities for Salesforce and Boundless Bio,

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Salesforce and Boundless is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Boundless Bio, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boundless Bio, Common and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Boundless Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boundless Bio, Common has no effect on the direction of Salesforce i.e., Salesforce and Boundless Bio, go up and down completely randomly.

Pair Corralation between Salesforce and Boundless Bio,

Considering the 90-day investment horizon Salesforce is expected to generate 0.42 times more return on investment than Boundless Bio,. However, Salesforce is 2.36 times less risky than Boundless Bio,. It trades about 0.23 of its potential returns per unit of risk. Boundless Bio, Common is currently generating about -0.1 per unit of risk. If you would invest  29,640  in Salesforce on August 31, 2024 and sell it today you would earn a total of  3,361  from holding Salesforce or generate 11.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Salesforce  vs.  Boundless Bio, Common

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
Boundless Bio, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Boundless Bio, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Salesforce and Boundless Bio, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Boundless Bio,

The main advantage of trading using opposite Salesforce and Boundless Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Boundless Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will offset losses from the drop in Boundless Bio,'s long position.
The idea behind Salesforce and Boundless Bio, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years